American Well Corporation (NYSE:AMWL) Receives $8.33 Consensus PT from Brokerages

American Well Corporation (NYSE:AMWL) has received a consensus recommendation of “Hold” from the eight research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $8.3333.

A number of analysts have recently issued reports on the company. Stifel Nicolaus reduced their target price on American Well from $8.00 to $6.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. Wall Street Zen downgraded American Well from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Wells Fargo & Company lowered their target price on American Well from $12.00 to $9.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of American Well in a report on Wednesday, October 8th.

Insider Buying and Selling at American Well

In other news, Director Deborah C. Jackson sold 4,531 shares of the business’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $6.56, for a total transaction of $29,723.36. Following the transaction, the director directly owned 39,132 shares in the company, valued at $256,705.92. The trade was a 10.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Phyllis Gotlib sold 4,959 shares of the company’s stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $6.11, for a total transaction of $30,299.49. Following the completion of the transaction, the insider directly owned 127,151 shares in the company, valued at $776,892.61. This trade represents a 3.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 44,852 shares of company stock worth $299,344. 12.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Goldman Sachs Group Inc. grew its stake in shares of American Well by 280.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company’s stock valued at $510,000 after buying an additional 47,745 shares in the last quarter. OMERS ADMINISTRATION Corp raised its position in American Well by 207.9% during the first quarter. OMERS ADMINISTRATION Corp now owns 32,331 shares of the company’s stock valued at $255,000 after acquiring an additional 21,831 shares in the last quarter. Corton Capital Inc. lifted its stake in American Well by 71.7% in the second quarter. Corton Capital Inc. now owns 27,402 shares of the company’s stock valued at $244,000 after acquiring an additional 11,445 shares during the last quarter. Acadian Asset Management LLC grew its position in American Well by 19.5% in the first quarter. Acadian Asset Management LLC now owns 188,217 shares of the company’s stock worth $1,481,000 after acquiring an additional 30,669 shares in the last quarter. Finally, Rock Point Advisors LLC grew its position in American Well by 49.3% in the third quarter. Rock Point Advisors LLC now owns 259,171 shares of the company’s stock worth $1,594,000 after acquiring an additional 85,581 shares in the last quarter. Hedge funds and other institutional investors own 56.05% of the company’s stock.

American Well Price Performance

American Well stock opened at $4.00 on Friday. American Well has a fifty-two week low of $3.83 and a fifty-two week high of $12.95. The firm’s 50 day simple moving average is $5.59 and its 200-day simple moving average is $6.79. The company has a market cap of $65.53 million, a P/E ratio of -0.56 and a beta of 1.24.

American Well (NYSE:AMWL) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($1.74) EPS for the quarter, beating the consensus estimate of ($1.83) by $0.09. American Well had a negative net margin of 42.80% and a negative return on equity of 39.80%. The business had revenue of $56.29 million during the quarter, compared to the consensus estimate of $54.56 million. American Well has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, analysts expect that American Well will post -9.34 EPS for the current fiscal year.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.